PIONEER

An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Stadium
klaar
Middel
rivaroxaban
Populatie
Ritme
Fase
IIIb
First Patient In
1 januari 2013
Last Patient In
31 juli 2015
Last Patient Last Visit
-

Studiedirecteur

dr. E. Ronner

Cardioloog

De pagina is verlopen.